肾病科管理下的慢性肾脏病对颈动脉内膜剥脱术结局的影响
单中心回顾性研究纳入675例颈动脉内膜剥脱术,按术前eGFR分层。CKD组围术期及4年MACE发生率有高于非CKD组的趋势但未达统计学显著。亚组分析显示,未接受肾病科管理的CKD患者围术期和4年全因死亡率显著高于非CKD患者,而接受肾病科管理的CKD患者结局与非CKD患者无显著差异。
要点
- CKD患者CEA后MACE风险有升高趋势,但差异未达统计学显著。
- 未接受肾病科管理的CKD患者围术期和4年全因死亡率显著高于非CKD患者。
- 接受肾病科管理的CKD患者CEA后结局与非CKD患者无显著差异。
核心结论
- CKD患者CEA后围术期及4年MACE风险有升高趋势但未达统计学显著。
- 未接受肾病科管理的CKD患者围术期和4年全因死亡率显著高于非CKD患者。
- 接受肾病科管理的CKD患者CEA后结局与非CKD患者无显著差异。
研究设计与样本
- 单中心回顾性观察性研究,2007年1月至2014年12月共675例CEA(613例患者)。
- 按术前eGFR分层:CKD组eGFR<60 mL/min/1.73m2,非CKD组eGFR≥60 mL/min/1.73m2。
- CKD组112例CEA(16.6%),非CKD组563例CEA(83.4%)。
主要发现
- 围术期MACE发生率CKD组4.5% vs 非CKD组1.8%(p=.086)。
- CEA后4年内MACE发生率CKD组17.9% vs 非CKD组11.5%(p=.066)。
- 未接受肾病科管理的CKD患者围术期全因死亡率4.1% vs 非CKD组0.4%(p=.037)。
- 未接受肾病科管理的CKD患者4年全因死亡率20.4% vs 非CKD组7.3%(p=.004)。
- 接受肾病科管理的CKD患者与非CKD患者围术期及4年MACE复合结局和各组分均无统计学显著差异。
临床怎么用
- CEA术前应评估eGFR以识别CKD患者。
- 对合并CKD的CEA患者,建议纳入肾病科管理以改善围术期及远期生存。
局限性
- 单中心回顾性观察性研究,可能存在选择偏倚和混杂。
- CKD亚组分析样本量较小(接受肾病科管理63例,未接受49例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to investigate the impact of chronic kidney disease (CKD) and the delivery of nephrology care on outcomes of carotid endarterectomy (CEA). METHODS: This was a single centre, retrospective observational study. Between January 2007 and December 2014, 675 CEAs performed on 613 patients were stratified by pre-operative estimated glomerular filtration rate (eGFR) values (CKD [eGFR < 60 mL/min/1.73m2] and non-CKD [eGFR ≥ 60 mL/min/1.73m2] groups) for retrospective analysis. The study outcomes included the occurrence of major adverse cardiovascular events (MACEs), defined as fatal or non-fatal stroke, myocardial infarction, or all cause mortality, during the peri-operative period and within four years after CEA. RESULTS: The CKD group consisted of 112 CEAs (16.6%), and the non-CKD group consisted of 563 CEAs (83.4%). The MACE incidence was higher among patients with CKD compared with non-CKD patients during the peri-operative period (4.5% vs. 1.8%; p = .086) and within four years after CEA (17.9% vs. 11.5%; p = .066), with a non-statistically significant trend. In a subgroup analysis of patients with CKD under nephrology care (63/112, 56.3%; with better controlled risk factors and tighter medical surveillance by a nephrologist), patients with CKD without nephrology care (49/112, 43.8%), and non-CKD patients, the risk of both peri-operative (4.1% vs. 0.4%; p = .037) and four year post-operative (20.4% vs. 7.3%; p = .004) all cause mortality was statistically significantly higher among patients with CKD without nephrology care compared with non-CKD patients. However, there were no statistically significant differences between patients with CKD who received nephrology care and non-CKD patients in peri-operative and four year post-operative MACE occurrence, both in terms of the composite MACE outcome and the individual MACE components. CONCLUSION: Despite the higher risk of peri-operative and four year MACE after CEA among patients with CKD, and the statistically significantly higher peri-operative and four year post-operative all cause mortality rates among patients with CKD without nephrology care, patients with CKD under nephrology care had similar outcomes to non-CKD patients.
引用
- Jeong MJ, Byun E, Chang JW, et al. Impact of Chronic Kidney Disease Under Nephrology Care on Outcomes of Carotid Endarterectomy. Eur J Vasc Endovasc Surg. 2021. PMID: 33632608. doi:10.1016/j.ejvs.2021.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。